Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis-Reference-Cited by-同舟云学术

Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis

Published:2012-08 Issue:2 Volume:22 Page:167-179
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Sander Sandrine,Calado Dinis P.,Srinivasan Lakshmi,Köchert Karl,Zhang Baochun,Rosolowski Maciej,Rodig Scott J.,Holzmann Karlheinz,Stilgenbauer Stephan,Siebert Reiner,Bullinger Lars,Rajewsky Klaus

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference40 articles.

1. Myc oncogene activation in B and T lymphoid tumours;Adams;Proc. R. Soc. Lond. B Biol. Sci.,1985

2. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling;Alizadeh;Nature,2000

3. Evolution of neoplastic cell lineages in Barrett oesophagus;Barrett;Nat. Genet.,1999

4. Estimation and assessment of raw copy numbers at the single locus level;Bengtsson;Bioinformatics,2008

5. The pattern of p53 mutations in Burkitt’s lymphoma differs from that of solid tumors;Bhatia;Cancer Res.,1992

Cited by 233 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Actinin‐4 controls survival signaling in B cells by limiting the lateral mobility of B‐cell antigen receptors;European Journal of Immunology;2024-02

2. Molecular Pathogenesis of B-Cell Lymphomas;Molecular Biology of B Cells;2024

3. Update: The molecular spectrum of virus-associated high-grade B-cell non-Hodgkin lymphomas;Blood Reviews;2024-01

4. Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy;Signal Transduction and Targeted Therapy;2023-11-06

5. Triple targeting of RSK, AKT, and S6K as pivotal downstream effectors of PDPK1 by TAS0612 in B‐cell lymphomas;Cancer Science;2023-10-15